[go: up one dir, main page]

BR9912409A - Processos de vacinação de uma ave doméstica, deredução de contaminação microbiana de avesdomésticas e de distribuição de uma proteìna emuma ave doméstica - Google Patents

Processos de vacinação de uma ave doméstica, deredução de contaminação microbiana de avesdomésticas e de distribuição de uma proteìna emuma ave doméstica

Info

Publication number
BR9912409A
BR9912409A BR9912409-2A BR9912409A BR9912409A BR 9912409 A BR9912409 A BR 9912409A BR 9912409 A BR9912409 A BR 9912409A BR 9912409 A BR9912409 A BR 9912409A
Authority
BR
Brazil
Prior art keywords
domestic
bird
protein
distribution
reduction
Prior art date
Application number
BR9912409-2A
Other languages
English (en)
Inventor
Sandra M Aehle
Original Assignee
Megan Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megan Health Inc filed Critical Megan Health Inc
Publication of BR9912409A publication Critical patent/BR9912409A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

"PROCESSOS DE VACINAçãO DE UMA AVE DOMéSTICA, DEREDUçãO DE CONTAMINAçãO MICROBIANA DE AVESDOMéSTICAS E DE DISTRIBUIçãO DE UMA PROTEìNA EMUMA AVE DOMéSTICA". é descrito um processo de vacinaçãode aves domésticas por meio de pulverização das aves domésticascom uma quantidade efetiva de um derivado avirulento vivo deuma enterobactéria enteropatogênica.
BR9912409-2A 1998-07-24 1999-07-13 Processos de vacinação de uma ave doméstica, deredução de contaminação microbiana de avesdomésticas e de distribuição de uma proteìna emuma ave doméstica BR9912409A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/122,299 US6713073B1 (en) 1998-07-24 1998-07-24 Method of vaccination of newly hatched poultry
PCT/US1999/015843 WO2000004920A2 (en) 1998-07-24 1999-07-13 Method of vaccination of newly hatched poultry

Publications (1)

Publication Number Publication Date
BR9912409A true BR9912409A (pt) 2001-12-11

Family

ID=22401889

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912409-2A BR9912409A (pt) 1998-07-24 1999-07-13 Processos de vacinação de uma ave doméstica, deredução de contaminação microbiana de avesdomésticas e de distribuição de uma proteìna emuma ave doméstica

Country Status (12)

Country Link
US (4) US6713073B1 (pt)
EP (1) EP1100461B1 (pt)
JP (1) JP2003529529A (pt)
CN (1) CN100346825C (pt)
AT (1) ATE295720T1 (pt)
AU (1) AU4991599A (pt)
BR (1) BR9912409A (pt)
CA (1) CA2338551C (pt)
DE (1) DE69925371T2 (pt)
ES (1) ES2243064T3 (pt)
MX (1) MXPA01000885A (pt)
WO (1) WO2000004920A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
CA2392344A1 (en) * 2001-07-02 2003-01-02 Nutratech Inc. Method for removal of pathogens from a localized environment
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
WO2003096812A1 (en) 2002-04-15 2003-11-27 Washington University Regulated attenuation of live vaccines to enhance cross protective immunogenicity
US7741109B2 (en) * 2004-06-02 2010-06-22 Watson James B Method for applying live bacteria liquid product
US8393294B2 (en) * 2004-06-02 2013-03-12 James B. Watson Live bacteria liquid product applicator and remote management system therefore
JP2008501458A (ja) 2004-06-07 2008-01-24 インターベツト・インターナシヨナル・ベー・ベー 生物活性組成物を送達するためのデバイス
JP5085547B2 (ja) * 2005-08-30 2012-11-28 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 生理活性ポリペプチドの細菌性送達
WO2007106073A2 (en) 2006-03-02 2007-09-20 University Of Massachusetts Modified pathogens for use as vaccines
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
CN104244972A (zh) 2012-03-22 2014-12-24 一般财团法人化学及血清疗法研究所 Lps疫苗
KR102071743B1 (ko) * 2012-09-06 2020-01-31 에벨리큐어 바이오테크놀로지스 게엠베하 신규의 약독화된 시겔라 생백신
RU2671473C2 (ru) * 2013-04-05 2018-10-31 Де Гавенерс Оф Де Юниверсити Оф Альберта Вакцина против кампилобактериоза
US10350041B2 (en) 2013-11-25 2019-07-16 Zoetis Services Llc Vaccination system for delivering vaccine to avian pullets, and associated methods, devices, and assemblies
US9763428B2 (en) 2013-11-25 2017-09-19 Zoetis Services Llc Holder apparatus for avian birds, and associated method
CA3090392C (en) * 2015-12-07 2021-06-01 Zymergen Inc. Microbial strain improvement by a htp genomic engineering platform
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
CN106125831B (zh) * 2016-06-17 2019-04-23 联想(北京)有限公司 旋转结构及电子设备
RU2692925C1 (ru) * 2018-12-07 2019-06-28 Константин Вячеславович Корсаков Способ увеличения продуктивности и выживаемости птицы
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
EP4132478A1 (en) 2020-04-09 2023-02-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US4316464A (en) 1981-03-09 1982-02-23 Select Laboratories, Inc. Poultry vaccination system
US4449968A (en) * 1981-03-09 1984-05-22 Select Laboratories, Inc. Poultry vaccination system
US4888170A (en) 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
DE3674299D1 (de) * 1985-08-01 1990-10-25 Harry Frankel Geraet zur zerstaeubungsvakzination.
US5294441A (en) * 1987-06-04 1994-03-15 Washington University Avirulent microbes and uses therefor: salmonella typhi
US5387744A (en) 1987-06-04 1995-02-07 Washington University Avirulent microbes and uses therefor: Salmonella typhi
US5468485A (en) 1987-06-04 1995-11-21 Washington University Avirulent microbes and uses therefor
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
AU637969B2 (en) 1987-10-07 1993-06-17 Washington University A method of maintaining a desired recombinant gene in a genetic population of cells
JP2849632B2 (ja) 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
AU5355990A (en) * 1989-03-31 1990-11-05 Washington University Avirulent microbes and uses therefor
JP3004049B2 (ja) 1989-03-31 2000-01-31 ワシントン ユニバーシティー 病原性のないｐｈｏＰ型微生物を含有するワクチン
US5312353A (en) 1993-03-24 1994-05-17 Boggess Gregory D Modular poultry automatic vaccine injection and spray apparatus
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry

Also Published As

Publication number Publication date
US6866847B1 (en) 2005-03-15
ES2243064T3 (es) 2005-11-16
CN100346825C (zh) 2007-11-07
ATE295720T1 (de) 2005-06-15
US20040180062A1 (en) 2004-09-16
CN1314809A (zh) 2001-09-26
US20040170639A1 (en) 2004-09-02
WO2000004920A3 (en) 2000-04-27
EP1100461A2 (en) 2001-05-23
CA2338551A1 (en) 2000-02-03
AU4991599A (en) 2000-02-14
MXPA01000885A (es) 2002-06-04
CA2338551C (en) 2007-10-02
JP2003529529A (ja) 2003-10-07
DE69925371T2 (de) 2006-01-19
WO2000004920A2 (en) 2000-02-03
US6713073B1 (en) 2004-03-30
EP1100461B1 (en) 2005-05-18
DE69925371D1 (de) 2005-06-23

Similar Documents

Publication Publication Date Title
BR9912409A (pt) Processos de vacinação de uma ave doméstica, deredução de contaminação microbiana de avesdomésticas e de distribuição de uma proteìna emuma ave doméstica
BR9713463A (pt) Fitase de bacillus subtilis, gene codificando a referida fitase, método para a produção e uso da mesma
ITMI20020399A1 (it) Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
ATE340581T1 (de) Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
HK1041521A1 (en) Growth differentiation factor inhibitors and uses therefor
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
DE69922933D1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
ATE447858T1 (de) Pharmazeutische zusammensetzung für muskelanabolismus
EP0203649A3 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
ATE320270T1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
EA199900633A1 (ru) Способы терапевтического введения анти-cd40l соединений
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
MX2007001931A (es) Aditivo alimentario.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
YU63291A (sh) Hibridni kalcitonin
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
BR9811004A (pt) "tratamento e prevenção de distúrbios cardìacos usando inibidores seletivos (ssri) da reelevação do nìvel de serotonina"
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
EA199700019A1 (ru) Способ увеличения прироста цыплят
WO2002038103A3 (en) Probiotic compositions and methods against bacterial infection in livestock animals
UA43187A (uk) Спосіб збереження сільськогосподарських тварин

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: AVANT IMMUNOTHERAPEUTICS, INC. (US)

Free format text: TRANSFERIDO DE: MEGAN HEALTH, INC.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 (VIII) E 32 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.